Mount Sinai Researchers Develop a First-in-Class Humanized Antibody Targeting Bone and Fat

Blocking the Follicle-Stimulating Hormone (FSH) whose levels rise at menopause could solve bone loss and weight gain Senior Author: Mone Zaidi, MD, PhD, MACP, Director of the Mount Sinai Bone Program and Professor of Medicine (Endocrinology, Diabetes and Bone Disease) at…

Two Widely-Used Drugs for Erectile Dysfunction Could Be Repurposed to Treat Osteoporosis

Why the Research Is Interesting: Osteoporosis is a global public health problem that affects almost 200 million people worldwide. Erectile dysfunction is the most common male sexual dysfunction in the aging population, with more than 70% of men over the…